Research organisation Molecular Profiles will demonstrate new drug-development services at the upcoming AAPS / FIP Pharmaceutical Sciences World Congress 2010.
Following a sustained period of investment into facilities, equipment and personnel the company has broadened its services within the early development space.
Designed to provide a de-risking approach to drug development, the services include formulation development activities with pre-formulation, polymorph screening, salt selection, analytical services and phase I clinical trial manufacturing, as well as existing analytical and characterisation suites.
Molecular Profiles will also be presenting four posters at the congress: De-risking early-stage formulation development of poorly water-soluble drugs by screening at the single-particulate level; Investigating solid-state microstructure and interactions in lactose: PVP pharmaceutical granules; Characterising the surface properties of pharmaceutical tooling components with atomic force microscopy; and A novel nanoscale approach for studying the structure and stability of solid dispersions.
